In 2020, the Roquette Foundation for Health launched the first edition of its Research Award. For young researchers, this Award rewarded any particularly innovative research, thesis, dissertation, or publication in the fields of food, nutrition, prevention in health, food of the futures or nutritional transition.
In 2022, the Roquette Foundation for Health launches the second edition of this Research Award. Endowed with €25,000, this Award is aimed at young researchers under 40 years old. It rewards or supports any particularly innovative research, thesis, dissertation, or publication that answers to the following question:
Prevention in Health: what are the challenges and strategies around food and nutrition?”
DO YOU WANT TO SUBMIT AN APPLICATION ?
You are a young researcher under 40 years old?
You work on health prevention related to food and nutrition?
In an European country*?
You are eligible for the 2022 Roquette Foundation Research Award!
The 2020 Research Award has been given to Laurent Reber (PhD) and his team for their work on food allergies.
A nominee in the category “Prevention in healthcare: what are the stakes and approaches around food and nutrition?”, the winning project led by Laurent Reber (PhD) highlights the key role played by a molecule called IgE (Immunoglobulin E) in food allergies. It is based on recent clinical studies showing that a therapeutic antibody can block this IgE and induce significant beneficial effects. Today, its cost remains very high and greatly reduces its potential as a therapy in the treatment of these allergies.
The project therefore consists in developing a new therapeutic approach: a vaccine that will offer a less costly and more effective solution in the long term. It will improve the life quality of many people suffering from food allergies.
"This support from the Roquette Foundation for Health is fundamental because this project represents a major potential breakthrough in the treatment of food allergies. A vaccine approach will make it possible to treat a larger number of patients in the long run. Therefore, we will be able to change the lives of these patients suffering from severe food allergies."